A Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, Immunogenicity and Anti-tumour Activity of IPN01203 in Adults With Locally Advanced or Metastatic Solid Tumours Exposed to Immune Checkpoint Inhibitor Therapies

计划入组 102 人 · 首次发布于 2025 年 10 月 9 日

A Study of IPN10200 for the Treatment of Cervical Dystonia in Adults

计划入组 132 人 · 首次发布于 2025 年 4 月 22 日

A Study to Assess the Safety and Efficacy of IPN10200 in Adult Participants With Moderate to Severe Upper Facial Lines

计划入组 727 人 · 首次发布于 2021 年 3 月 29 日

SPN0103-009

Marengo Therapeutics Reports Confirmed Complete Responses in Phase 2 Trial of Invikafusp Alfa Plus TRODELVY for Metastatic Breast Cancer

Ipsen's IPN10200 Shows Superior Long-Term Efficacy in Phase II Glabellar Lines Trial